peripheral artery disease treatment
Oct 15, 2026
B. Braun Receives Medicare Payment Approval for Peripheral Nerve Block Devices; FDA Approves Providence Medical’s CORUS PCSS 3D-T Spinal Device; PurMinds Enters Clinical Validation Collaboration with SpectroChip and Taiwan-Based Hospital; MemorialCare Leads South Los Angeles County in Robotic-Assisted Shoulder Replacement Technology; Clinical Study Demonstrates the Potential of Home-Based Diuretic Delivery for Heart Failure; VIVA 2026 Highlights New Clinical Trial Results
B. Braun Peripheral Nerve Block Devices Approved for Separate Medicare Payment Under the NOPAIN Act On 14 October 2026, B. Braun Medical announced that the U.S. Centers for Medicare and Medicaid Services had approved its Stimuplex Single-Shot Nerve Block Needles as qualifying non-opioid medical devices und...
Read More...
Mar 31, 2023
Peripheral Artery Disease Treatment: Role of Cell Therapies in Restoring Blood Circulation & Limb Function
Peripheral artery disease (PAD) is one of the leading causes of cardiovascular morbidity, affecting 12-14% of the world’s population. Peripheral artery disease affects six times more people worldwide than HIV. 1 in 3 diabetics over age 50 suffer from peripheral artery disease. In addition, 1 in every 20 Americans o...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
